Cite
HARVARD Citation
Keane, C. et al. (2019). The tumour microenvironment is immuno‐tolerogenic and a principal determinant of patient outcome in EBV‐positive diffuse large B‐cell lymphoma. European journal of haematology. pp. 200-207. [Online].